JP Morgan Chase’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

JP Morgan Chase’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-138,785	Closed	-$19.2M	–	6172
2020 Q3	$19.2M	Sell	138,785 -44,803	-24%	-$5.46M	﹤0.01%	1517
2020 Q2	$13.8M	Buy	183,588 +32,753	+22%	+$1.71M	﹤0.01%	1657
2020 Q1	$4.3M	Sell	150,835 -110,080	-42%	-$2.85M	﹤0.01%	2390
2019 Q4	$6.54M	Buy	260,915 +143,811	+123%	+$3.44M	﹤0.01%	2473
2019 Q3	$2.04M	Buy	+117,104	New	+$3.54M	﹤0.01%	3405

JP Morgan Chase's LVGO Position: Q4 2020 in Review

JP Morgan Chase sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 138,785 shares — an estimated $19.2M sold.

JP Morgan Chase first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $19.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

JP Morgan Chase reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
JP Morgan Chase sold 138,785 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19.2M.
JP Morgan Chase first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
JP Morgan Chase's Livongo Health, Inc. Common Stock position peaked at $19.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.